Siegfried Holding AG saw higher earnings in the first half of 2017 with cost synergies offsetting the negative impact facility maintenance work had on its API business.
This month’s roundup features LabCorp newly created enterprise-wide chief medical officer position and two new hires at WIRB-Copernicus Group’s eCOA arm.
CordenPharma Latina has resolved the problems that earned its API and injectable drug facility in Sermoneta, Italy a warning letter from the US FDA last year.
Genoskin SAS collects donated human skin samples, which are kept alive in an ex vivo culture system for preclinical testing, and plans to raise €1m ($1.2m) to setup its first US-based facility.
AstraZeneca has said it will wait to see how Brexit negotiations progress before deciding whether to make mid-to-large scale manufacturing investments in the UK.
Price controls and procurement programmes would favour drugs containing locally-made APIs under a Government proposal designed to reduce India's reliance on imported ingredients and intermediates.
Ajinomoto Althea, Inc. has added a new aseptic fill/finish line in response to client's concerns regarding active pharmaceutical ingredient (API) manufacturing costs.
Eurofins Pharma Bioanalytical Services has launched a consulting program to support clients conducting large molecule preclinical and clinical studies.
CordenPharma has implemented work to improve its quality and compliance systems after its Latina facility was issued a warning letter from the US FDA in May of last year.
Trial By Fire Solutions has released SimpleTrials 2.0, an upgraded version of its clinical trial management system (CTMS) with new features including site contracts and payments management.
Parexel's alliance with the Osaka International Cancer Institute focuses on supporting efficient patient recruitment and advancing new cancer treatments.
The US FDA has released draft guidelines to identify trading partners in the pharma supply chain in accordance with the Drug Supply Chain Security Act (DSCSA).
Clinerion recently filed a patent for its “anonymized identification” (ANID) technology, the use of which avoids possible privacy concerns associated with electronic patient data, says CEO.
The combined offering leverages Elligo’s infrastructure and services to enable Allscripts physicians to participate as study investigators in contract research organization-managed (CRO) clinical trials.
The commercial compliance solutions company is expanding its footprint with a new office and anticipates further growth in the US and internationally to keep pace with client demand, says CEO.
Hikma has ramped up capacity at manufacturing facilities in the US and Portugal manufacturing to meet the growing demand for its lyophilised and oncology products.
Merck & Co has launched a promotional campaign featuring US singer and actress Mandy Moore, which marketing expert John Mack says targets America’s celebrity-obsessed market.
The New Zealand Commerce Commission has issued warnings to GlaxoSmithKline and AFT Pharmaceuticals for marketing products which contain the same active ingredients for different indications.
Bioprocessing suppliers have recently expressed optimism in the sector despite a slowdown in growth, and one expert believes this will drive investment in new tech and markets.
Contract research organization (CRO) earnings reports have been filing in over the past few weeks – and as a group, performance was positive following concerns around slowing outsourcing trends.
Researchers have developed and tested a method to determine how relevant mouse models are to human disease to better enable comparison of pharmacological targets across species.
